RaimaDB
RaimaDB, an embedded time series database that can be used for Edge and IoT devices, can run in-memory. It is a lightweight, secure, and extremely powerful RDBMS. It has been field tested by more than 20 000 developers around the world and has been deployed in excess of 25 000 000 times.
RaimaDB is a high-performance, cross-platform embedded database optimized for mission-critical applications in industries such as IoT and edge computing. Its lightweight design makes it ideal for resource-constrained environments, supporting both in-memory and persistent storage options. RaimaDB offers flexible data modeling, including traditional relational models and direct relationships through network model sets. With ACID-compliant transactions and advanced indexing methods like B+Tree, Hash Table, R-Tree, and AVL-Tree, it ensures data reliability and efficiency. Built for real-time processing, it incorporates multi-version concurrency control (MVCC) and snapshot isolation, making it a robust solution for applications demanding speed and reliability.
Learn more
Vertex AI
Fully managed ML tools allow you to build, deploy and scale machine-learning (ML) models quickly, for any use case.
Vertex AI Workbench is natively integrated with BigQuery Dataproc and Spark. You can use BigQuery to create and execute machine-learning models in BigQuery by using standard SQL queries and spreadsheets or you can export datasets directly from BigQuery into Vertex AI Workbench to run your models there. Vertex Data Labeling can be used to create highly accurate labels for data collection.
Vertex AI Agent Builder empowers developers to design and deploy advanced generative AI applications for enterprise use. It supports both no-code and code-driven development, enabling users to create AI agents through natural language prompts or by integrating with frameworks like LangChain and LlamaIndex.
Learn more
AlphaFold
Proteins, which are remarkably complex machines, play a crucial role not only in the biological functions of your body but also in every living organism's processes. They serve as the fundamental units of life. As of now, there are approximately 100 million identified proteins, with discoveries being made regularly. Each protein possesses a distinctive three-dimensional shape that is essential to its functionality and purpose. However, determining a protein's precise structure is often a costly and lengthy endeavor, resulting in an understanding of only a small percentage of the proteins recognized by science. Addressing this growing disparity and developing methods to predict the structures of millions of yet-to-be-discovered proteins could significantly advance our ability to combat diseases, expedite the discovery of new treatments, and potentially unveil the secrets of life's mechanisms. The implications of such advancements could transform both medicine and our understanding of biology.
Learn more
3decision
3decision® serves as a cloud-based repository for protein structures, focusing on efficient management of structural data and offering sophisticated analytics to support teams involved in the discovery of small molecules and biologics, thereby expediting the process of structure-based drug design.
The platform consolidates and standardizes both experimental and computational protein structures sourced from publicly available databases such as RCSB PDB and AlphaFoldDB, in addition to proprietary datasets, and accommodates formats like PDBx/mmCIF and ModelCIF. This comprehensive approach guarantees seamless access to a variety of structural formats including X-Ray, NMR, cryo-EM, and modeled structures, thereby promoting collaboration and bolstering research initiatives.
In addition to its storage capabilities, 3decision® enhances each entry with valuable metadata and sequence information, which encompasses details on protein-ligand interactions, antibody annotations, and specifics about binding sites. Equipped with advanced analytical instruments, the platform is capable of pinpointing druggable sites, evaluating off-target risks, and facilitating comparisons of binding sites, which collectively transform extensive structural datasets into practical insights that can drive research forward.
Furthermore, its cloud-based architecture fosters enhanced collaboration among research teams, making it easier for scientists to share findings and insights, ultimately leading to more innovative approaches in drug discovery and development.
Learn more